Link to this page
National Cancer Institute Thesaurus
Preferred Name | Ambrisentan | |
Synonyms |
(+-)-(2S)-2-((4,6-Dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic Acid AMBRISENTAN Ambrisentan BSF-208075 LU-208075 Letairis Pulmonext Volibris |
|
Definitions |
An orally bioavailable, selective antagonist of the endothelin type-A (ETA) receptor that may be used for the treatment of pulmonary arterial hypertension (PAH). Upon administration, ambrisentan targets and binds to ETA receptor, which prevents the binding of endothelin-1 (ET-1) to the ETA receptor and ET-1/ETA-mediated vasoconstriction and cell proliferation. This may lead to vasodilation. ET-1 concentrations are increased in plasma as well as lung tissue in PAH, and ET-1 may play a key role in the pathogenesis of PAH. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C72694 |
|
CAS_Registry |
177036-94-1
|
|
Chemical_Formula |
C22H22N2O4
|
|
code |
C72694
|
|
Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C173381 |
|
Contributing_Source |
FDA
|
|
DEFINITION |
An orally bioavailable, selective antagonist of the endothelin type-A (ETA) receptor that may be used for the treatment of pulmonary arterial hypertension (PAH). Upon administration, ambrisentan targets and binds to ETA receptor, which prevents the binding of endothelin-1 (ET-1) to the ETA receptor and ET-1/ETA-mediated vasoconstriction and cell proliferation. This may lead to vasodilation. ET-1 concentrations are increased in plasma as well as lung tissue in PAH, and ET-1 may play a key role in the pathogenesis of PAH.
|
|
FDA_UNII_Code |
HW6NV07QEC
|
|
FULL_SYN |
(+-)-(2S)-2-((4,6-Dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic Acid AMBRISENTAN Ambrisentan BSF-208075 LU-208075 Letairis Pulmonext Volibris
|
|
label |
Ambrisentan
|
|
Legacy Concept Name |
Ambrisentan
|
|
Preferred_Name |
Ambrisentan
|
|
prefixIRI |
Thesaurus:C72694
|
|
Semantic_Type |
Pharmacologic Substance
|
|
UMLS_CUI |
C1176329
|
|
subClassOf |
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |